Application of machine learning algorithms to identify serological predictors of COVID-19 severity and outcomes

应用机器学习算法识别 COVID-19 严重程度和结果的血清学预测因子

阅读:6
作者:Santosh Dhakal #, Anna Yin #, Marta Escarra-Senmarti #, Zoe O Demko, Nora Pisanic, Trevor S Johnston, Maria Isabel Trejo-Zambrano, Kate Kruczynski, John S Lee, Justin P Hardick, Patrick Shea, Janna R Shapiro, Han-Sol Park, Maclaine A Parish, Christopher Caputo, Abhinaya Ganesan, Sarika K Mullapudi, 

Background

Critically ill hospitalized patients with COVID-19 have greater antibody titers than those with mild to moderate illness, but their association with recovery or death from COVID-19 has not been characterized.

Conclusions

At enrollment, serological antibody measures are more predictive than demographic variables of subsequent intubation or death among hospitalized COVID-19 patients.

Methods

In a cohort study of 178 COVID-19 patients, 73 non-hospitalized and 105 hospitalized patients, mucosal swabs and plasma samples were collected at hospital enrollment and up to 3 months post-enrollment (MPE) to measure virus RNA, cytokines/chemokines, binding antibodies, ACE2 binding inhibition, and Fc effector antibody responses against SARS-CoV-2. The association of demographic variables and more than 20 serological antibody measures with intubation or death due to COVID-19 was determined using machine learning algorithms.

Results

Predictive models reveal that IgG binding and ACE2 binding inhibition responses at 1 MPE are positively and anti-Spike antibody-mediated complement activation at enrollment is negatively associated with an increased probability of intubation or death from COVID-19 within 3 MPE. Conclusions: At enrollment, serological antibody measures are more predictive than demographic variables of subsequent intubation or death among hospitalized COVID-19 patients.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。